Hans Jeppsson
Director Financiero/CFO en VICORE PHARMA HOLDING AB .
Fortuna: 8 227 $ al 30/04/2024
Cargos activos de Hans Jeppsson
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| VICORE PHARMA HOLDING AB | Director Financiero/CFO | 01/01/2017 | - |
| Public Communications Contact | 01/01/2017 | - | |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Corporate Officer/Principal | - | - |
INIM Pharma AB
 INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Director/Miembro de la Junta | - | - |
Historial de carrera de Hans Jeppsson
Antiguos cargos conocidos de Hans Jeppsson.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Danske Bank A/S (Sweden) | Analyst-Equity | - | - |
Formación de Hans Jeppsson.
| University of Gothenburg | Doctorate Degree |
| Handelshögskolan i Göteborg | Doctorate Degree |
Estadísticas
Internacional
| Suecia | 7 |
Operativa
| Doctorate Degree | 2 |
| Graduate Degree | 2 |
| Analyst-Equity | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| VICORE PHARMA HOLDING AB | Health Technology |
| Empresas privadas | 3 |
|---|---|
| Danske Bank A/S (Sweden) | Finance |
Vicore Pharma AB
Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Health Technology |
INIM Pharma AB
INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- Hans Jeppsson
- Experiencia